Schizophrenia

The Pharmacy Times® Schizophrenia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for schizophrenia.

Latest News

Mental health conditions, schizophrenia diagnosis and treatment with antipsychotic medication and psychotherapy.
Lumateperone Demonstrates Positive Efficacy for Schizophrenia Relapse Prevention

November 11th 2024

In the trial, lumateperone had a significantly longer time to relapse in patients treated compared to placebo.

Schizophrenia disorder and psychiatric disease or mental health as a psychiatry and psychology concept for human abnormal personality behavior and mood illness
Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

October 14th 2024

Schizophrenia FDA Approval | Image Credit: Aquir - stock.adobe.com
FDA Approves Cobenfy, Previously KarXT, for Treatment of Schizophrenia

September 27th 2024

FDA Approval | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Long-Acting Injectable Paliperidone for Schizophrenia Treatment

July 29th 2024

If dreams come true, can nightmares too. Shot of a young man sitting in the corner of a dark room with a scary figure on the wall - Image credit: Siphosethu Fanti/peopleimages.com | stock.adobe.com
Study: Probiotic with Vitamin D Supplements Could Aid Individuals with Schizophrenia

April 30th 2024

More News